- Filed
- Nov 10, 2021 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2021 · Oct 25, 2021 | 190.89M sh |
| Short Term Investments | Q3 2021 · Sep 30, 2021 | $120.24M |
| Short Term Investments | Q3 2021 · Dec 31, 2020 | $570.02M |
| Current Liabilities | Q3 2021 · Sep 30, 2021 | $208.98M |
| Current Liabilities | Q3 2021 · Dec 31, 2020 | $117.43M |
| Total Liabilities | Q3 2021 · Sep 30, 2021 | $921.88M |
| Total Liabilities | Q3 2021 · Dec 31, 2020 | $522.52M |
| Current Assets | Q3 2021 · Sep 30, 2021 | $747.13M |
| Current Assets | Q3 2021 · Dec 31, 2020 | $774.7M |
| Total Assets | Q3 2021 · Sep 30, 2021 | $2.71B |
| Total Assets | Q3 2021 · Dec 31, 2020 | $1.07B |
| Cost Of Revenue | Q3 2021 · Sep 30, 2021 | $78.44M |
| Cost Of Revenue | Q3 2021 · Sep 30, 2021 | $216.46M |
| Cost Of Revenue | Q3 2021 · Sep 30, 2020 | $58.78M |
| Cost Of Revenue | Q3 2021 · Sep 30, 2020 | $163.78M |
| Shares Diluted | Q3 2021 · Sep 30, 2020 | 128.56M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2020 | 113.25M sh |
| Capex | Q3 2021 · Sep 30, 2020 | $51.49M |
| Operating Cash Flow | Q3 2021 · Sep 30, 2020 | −$5.99M |
| Cash And Equivalents | Q3 2021 · Sep 30, 2020 | $161.47M |
| Cash And Equivalents | Q3 2021 · Dec 31, 2019 | $27.39M |
| Eps Diluted | Q3 2021 · Sep 30, 2020 | −$0.13 |
| Eps Diluted | Q3 2021 · Sep 30, 2020 | −$0.71 |
| Eps Basic | Q3 2021 · Sep 30, 2020 | −$0.13 |
| Eps Basic | Q3 2021 · Sep 30, 2020 | −$0.71 |
| Sga Expense | Q3 2021 · Sep 30, 2020 | $40.06M |
| Sga Expense | Q3 2021 · Sep 30, 2020 | $118.24M |
| Net Income | Q3 2021 · Sep 30, 2020 | −$16.42M |
| Net Income | Q3 2021 · Sep 30, 2020 | −$80.57M |
| Operating Income | Q3 2021 · Sep 30, 2020 | −$10.82M |
| Operating Income | Q3 2021 · Sep 30, 2020 | −$68.56M |
| Revenue | Q3 2021 · Sep 30, 2020 | $101.67M |
| Revenue | Q3 2021 · Sep 30, 2020 | $258.42M |